Clinical Trial Update: A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation. [Phase 1]

View source ↗

Summary

A Phase I, single-arm study evaluating donor NK cell infusion combined with low-dose interleukin-2 for relapse of acute myeloid leukemia after allogeneic hemato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Donor NK cell infusion (Natural killer cells)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Peking University First Hospital | Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse | Phase 1 | Status: NOT_YET_RECRUITING